-
July 28, 2021
2021 ASCO Annual Meeting Bookmark
George Lundberg, MDResearchers at the 2021 annual meeting of the American Society of Clinical Oncology (ASCO) reported substantial advances in treatment for advanced esophageal, castration-resistant prostate, and metastatic nasopharyngeal cancers.
.
-
July 28, 2021
FDA Approves First Targeted Therapy for Lung Cancer Mutation Previously Considered Resistant to Drug Therapy Bookmark
George Lundberg, MDOn May 28, 2021, the U.S. Food and Drug Administration granted Accelerated Approval for Lumakras (sotorasib), the first targeted therapy for cancer with a mutation in the KRAS gene.
.
-
July 28, 2021
Advances in Colorectal Cancer Research Bookmark
George Lundberg, MDThis outline from the National Cancer Institute covers recent research on colorectal cancer.
.
-
July 14, 2021
What’s New in Melanoma Treatment in 2021?
Emma Shtivelman, PhDI last wrote about melanoma treatment more than 2 years ago, a fairly long time in the evolution of treatments for this type of cancer. Just as a refresher, the current mainstays of drugs to treat melanoma fall into two categories: Now, I highlight new developments in melanoma treatment, including overcoming resistance to ICI. Neoadjuvant (before surgery) treatments for resectable melanoma Some stage III… Read more »
-
June 12, 2021
NALIRIFOX Shows Promise in Early Studies Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: NALIRIFOX, a combination of liposomal irinotecan (Onivyde) with fluorouracil (5-FU), leucovorin, and oxaliplatin is shown to be safe as a first line treatment in locally advanced or metastatic pancreatic cancer.
.
-
June 12, 2021
Multi-Site Precision Promise Study Opens Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Learn about Precision Promise, an adaptive multi-site clinical trial spearheaded by the Pancreatic Cancer Action Network.
.
-
June 12, 2021
New Trial to Find Biomarkers to Guide Treatment Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: A new clinical trial is using precision medicine to identify the best individualized standard-of-care options for pancreatic cancer patients.
.
-
June 12, 2021
New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Modified FOLFIRINOX shows benefit as neoadjuvant therapy for borderline resectable pancreatic cancer.
.
-
May 20, 2021
When is the Best Time to Seek a Clinical Trial for Glioblastoma?
With:For some people with glioblastoma brain tumors, enrolling in a clinical trial enables access to cutting-edge treatment. Here, our Curious Dr. George talks clinical trials with Cancer Commons Expert Physician Advisor, Eric T. Wong, MD. Dr. Wong is also Associate Professor of Neurology at Harvard Medical School and Co-Director of the Brain Tumor Center at Beth Israel Deaconess Medical Center. Curious Dr. George: Malignant… Read more »
-
May 4, 2021
Hepatocellular Carcinoma (HCC)—An Overview Bookmark
George Lundberg, MDOverview from Medscape curated by Contributing Editor George Lundberg, MD, who notes:
This 2020 encyclopedic approach to all of the many diagnostic and therapeutic options available for primary hepatocellular carcinoma leaves no stone unturned. (Free registration required, written with a physician audience in mind.)
.